Back
Project Title: A phase 3 Open label partial randomized trial to evaluate the efficacy safety and tolerability of the combination of Moxifloxacin plus PA-82A plus smear positive pulmonary tuberculosis in after 6 months of treatment in Adult subjects with Multi-drug Resistant, smear positive pulmonary Tuberculosis
Project Description: xxxxxxxxxx xxxxxxxxxx
Principal Investigator : Francis Mhimbira
Department Name : BRCT
Time frame: (2015-01-01) - (2018-12-31)
Funding Partners
Global Alliance for TB Drug Development (TB-Alliance) (Normal)
External Collaborating Partners
None added yet.
Global Alliance for TB Drug Development (TB-Alliance) (Normal)
External Collaborating Partners
None added yet.